HRCM
PRAX icon

Hood River Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Hood River Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142M Buy
425,167
+66,549
+19% +$21.1M 1.03% 26
2026
Q1 		$116M Buy
358,618
+69,151
+24% +$21.4M 1.16% 20
2025
Q4 		$85.3M Buy
+289,467
New +$53.9M 0.94% 38

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Hood River Capital Management's PRAX Position: Q2 2026 in Review

Hood River Capital Management increased its Praxis Precision Medicines (PRAX) stake by 19% in Q2 2026, buying an estimated $21.1M and bringing the position to 425,167 shares worth $142M. The position accounts for 1.03% of the portfolio, ranked #26.

Hood River Capital Management first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Hood River Capital Management held 425,167 shares of Praxis Precision Medicines worth $142M as of Q2 2026.
  • Hood River Capital Management bought 66,549 Praxis Precision Medicines shares in Q2 2026, an estimated $21.1M.
  • Praxis Precision Medicines made up 1.03% of Hood River Capital Management's portfolio in Q2 2026, its #26 holding.
  • Hood River Capital Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Hood River Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.